Skip to Content
You are currently on the new version of our website. Access the old version .
  • Article
  • Open Access

22 March 2023

12 Pages

A Novel One-Pot Synthesis of PVP-Coated Iron Oxide Nanoparticles as Biocompatible Contrast Agents for Enhanced T2-Weighted MRI

,
,
,
,
,
and
1
Physics Department, Jordan University of Science and Technology, Irbid 22110, Jordan
2
Nano-Biotechnology Research and Innovation (NanoBRI), Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Pulau Pinang 11800, Malaysia
3
College of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait
4
Medical Imaging and Radiography Department, Aqaba University of Technology, Aqaba 910122, Jordan
This article belongs to the Section Biocomposites

Abstract

A contrast agent with specific characteristics is essential for high-quality magnetic resonance imaging (MRI). It plays a crucial role in enhancing the visibility of certain tissues and structures, making it imperative for diagnostic procedures. Superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as a promising alternative to traditional contrast agents for MRI due to their non-toxicity and superior magnetic properties. However, a suitable surface coating strategy is needed to produce polymer-coated SPIONs with controllable sizes in order to enhance their stability and biocompatibility. This study presents a novel one-pot synthesis method for the production of highly stable polyvinylpyrrolidone (PVP)-coated SPIONs. By systematically manipulating the physicochemical properties of SPIONs, the effect of different molecular weights of PVP was studied. The results showed that SPIONs coated with PVP with molecular wight 40,000 g/mol (40 K) exhibited a high magnetization (Ms = 48.4 emu/g), an average size distribution (11.61 nm), and excellent stability. The relaxivity of coated and uncoated SPIONs was investigated using MRI images. The results revealed that the (r2/r1) ratio of PVP40K-SPIONs was 72.55, compared to 55.72 for the bare SPIONs, making them a highly promising T2-contrast agent for future development of MRI applications. This study opens new avenues for the development of biocompatible and stable SPIONs for improved medical diagnostic and imaging.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.